NANTES, France--(BUSINESS WIRE)--OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the Company has entered into a collaboration with GenDx (a Eurobio Scientific Company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback